Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.39 AUD | +2.87% |
|
+3.99% | -3.81% |
18/06 | Clinuvel Pharmaceuticals' Afamelanotide Found Effective in Fair-Skinned Parkinson’s Patients | MT |
18/06 | CLINUVEL Announces A Novel Clinical Program | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.81% | 51Cr | |
+2.22% | 9.39TCr | |
-1.32% | 3.84TCr | |
-13.44% | 3.26TCr | |
+76.30% | 2.82TCr | |
-13.11% | 1.59TCr | |
+0.68% | 1.42TCr | |
-12.06% | 1.15TCr | |
+185.28% | 1.07TCr | |
-53.00% | 946.85Cr |
- Stock Market
- Equities
- CUV Stock
- News Clinuvel Pharmaceuticals Limited
- Clinuvel Pharmaceuticals Partners Valentech Pharma to Introduce EPP Drug in Latin America